Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1967 1
1974 1
1979 1
1981 2
1982 1
1983 1
1984 1
1985 1
1986 2
1987 7
1989 1
1990 1
1991 1
1992 2
1993 2
1994 1
1995 6
1996 11
1997 4
1998 15
1999 6
2000 8
2001 5
2002 5
2003 2
2004 2
2005 6
2006 5
2007 4
2008 7
2009 4
2010 5
2011 8
2012 7
2013 3
2014 10
2015 6
2016 9
2017 12
2018 8
2019 7
2020 18
2021 9
2022 4
2023 3
2024 7
2025 4

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

228 results

Results by year

Filters applied: . Clear all
Page 1
Dolutegravir plus lamivudine versus dolutegravir plus tenofovir disoproxil fumarate and emtricitabine in antiretroviral-naive adults with HIV-1 infection (GEMINI-1 and GEMINI-2): week 48 results from two multicentre, double-blind, randomised, non-inferiority, phase 3 trials.
Cahn P, Madero JS, Arribas JR, Antinori A, Ortiz R, Clarke AE, Hung CC, Rockstroh JK, Girard PM, Sievers J, Man C, Currie A, Underwood M, Tenorio AR, Pappa K, Wynne B, Fettiplace A, Gartland M, Aboud M, Smith K; GEMINI Study Team. Cahn P, et al. Lancet. 2019 Jan 12;393(10167):143-155. doi: 10.1016/S0140-6736(18)32462-0. Epub 2018 Nov 9. Lancet. 2019. PMID: 30420123 Clinical Trial.
The p53 network.
Agarwal ML, Taylor WR, Chernov MV, Chernova OB, Stark GR. Agarwal ML, et al. Among authors: chernova ob. J Biol Chem. 1998 Jan 2;273(1):1-4. doi: 10.1074/jbc.273.1.1. J Biol Chem. 1998. PMID: 9417035 Free article. Review. No abstract available.
Omics of antimicrobials and antimicrobial resistance.
Chernov VM, Chernova OA, Mouzykantov AA, Lopukhov LL, Aminov RI. Chernov VM, et al. Among authors: chernova oa. Expert Opin Drug Discov. 2019 May;14(5):455-468. doi: 10.1080/17460441.2019.1588880. Epub 2019 Mar 19. Expert Opin Drug Discov. 2019. PMID: 30884978 Review.
Antimicrobial drug resistance mechanisms among Mollicutes.
Chernova OA, Chernov VM, Mouzykantov AA, Baranova NB, Edelstein IA, Aminov RI. Chernova OA, et al. Int J Antimicrob Agents. 2021 Feb;57(2):106253. doi: 10.1016/j.ijantimicag.2020.106253. Epub 2020 Nov 29. Int J Antimicrob Agents. 2021. PMID: 33264670 Review.
Mycoplasmas and Novel HO-1 Inducers: Recent Advances.
Chernov VM, Chernova OA, Mouzykantov AA, Lopukhov LV, Trushin MV. Chernov VM, et al. Among authors: chernova oa. Curr Pharm Des. 2018;24(20):2236-2240. doi: 10.2174/1381612824666180716170128. Curr Pharm Des. 2018. PMID: 30014797 Review.
Targeting NAD+ Metabolism Vulnerability in FH-Deficient Hereditary Leiomyomatosis and Renal Cell Carcinoma with the Novel NAMPT Inhibitor OT-82.
Najera SS, Ricketts CJ, Schmidt LS, Medina JI, Saito K, Ileva L, Brender JR, James AM, Peer CJ, Gouker B, Karim BO, Chernova O, Wells C, Wei MH, Yang Y, Zhang X, Klumpp-Thomas C, Travers J, Chen L, Wilson KM, Issaq SH, Figg WD, Difilippantonio S, Kalen JD, Krishna MC, Thomas CJ, Ceribelli M, Heske CM, Crooks DR, Meier JL. Najera SS, et al. Among authors: chernova o. Mol Cancer Ther. 2025 Feb 4;24(2):200-213. doi: 10.1158/1535-7163.MCT-24-0225. Mol Cancer Ther. 2025. PMID: 39397296 Free PMC article.
[Mycoplasmas].
Borkhsenius SN, Chernova OA. Borkhsenius SN, et al. Among authors: chernova oa. Tsitologiia. 1987 Apr;29(4):379-90. Tsitologiia. 1987. PMID: 2440162 Russian.
228 results